Download Files:
Products Details
Product Description
– Cap-dependent endonuclease-IN-13 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-13 has the potential for the research of influenza virus infection (only influenza A) (extracted from patent WO2021180147A1, compound I-1)[1].
Web ID
– HY-143766
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C25H20F2N4O4S
References
– [1]Zhen Xu, et al. An influenza virus inhibitor. Patent WO2021180147A1.
CAS Number
– 2703046-60-8
Molecular Weight
– 510.51
SMILES
– O=C1N2[C@](C/C(CC2)=N/O)([H])N([C@H]3C4=CC=C(F)C(F)=C4CSC5=CC=CC=C53)N6C1=C(C(C=C6)=O)O
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– Influenza Virus
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation.
